nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—CXCL8—pancreatic cancer	0.267	0.774	CbGaD
Diclofenac—PTGS2—pancreatic cancer	0.078	0.226	CbGaD
Diclofenac—UGT2B7—Epirubicin—pancreatic cancer	0.0281	0.0659	CbGbCtD
Diclofenac—UGT1A1—Erlotinib—pancreatic cancer	0.0262	0.0613	CbGbCtD
Diclofenac—UGT1A1—Irinotecan—pancreatic cancer	0.0236	0.0554	CbGbCtD
Diclofenac—ABCC4—Fluorouracil—pancreatic cancer	0.0232	0.0543	CbGbCtD
Diclofenac—ABCC1—Epirubicin—pancreatic cancer	0.02	0.0468	CbGbCtD
Diclofenac—CYP1A1—Dacarbazine—pancreatic cancer	0.0196	0.046	CbGbCtD
Diclofenac—ABCC1—Irinotecan—pancreatic cancer	0.0194	0.0455	CbGbCtD
Diclofenac—ABCC4—Sunitinib—pancreatic cancer	0.0176	0.0413	CbGbCtD
Diclofenac—CYP1A1—Tamoxifen—pancreatic cancer	0.0156	0.0366	CbGbCtD
Diclofenac—CYP2E1—Dacarbazine—pancreatic cancer	0.0152	0.0355	CbGbCtD
Diclofenac—ABCC1—Docetaxel—pancreatic cancer	0.0142	0.0333	CbGbCtD
Diclofenac—CYP1A1—Erlotinib—pancreatic cancer	0.0133	0.0311	CbGbCtD
Diclofenac—CYP2E1—Tamoxifen—pancreatic cancer	0.0121	0.0283	CbGbCtD
Diclofenac—CYP2B6—Tamoxifen—pancreatic cancer	0.0119	0.0279	CbGbCtD
Diclofenac—ABCC1—Doxorubicin—pancreatic cancer	0.0106	0.0249	CbGbCtD
Diclofenac—ALB—Erlotinib—pancreatic cancer	0.00992	0.0232	CbGbCtD
Diclofenac—CYP2B6—Irinotecan—pancreatic cancer	0.00914	0.0214	CbGbCtD
Diclofenac—CYP2C8—Tamoxifen—pancreatic cancer	0.00901	0.0211	CbGbCtD
Diclofenac—ALB—Irinotecan—pancreatic cancer	0.00895	0.021	CbGbCtD
Diclofenac—CYP1A2—Dacarbazine—pancreatic cancer	0.00877	0.0206	CbGbCtD
Diclofenac—ALB—Fluorouracil—pancreatic cancer	0.00859	0.0201	CbGbCtD
Diclofenac—CYP2C8—Erlotinib—pancreatic cancer	0.00766	0.018	CbGbCtD
Diclofenac—CYP2C19—Tamoxifen—pancreatic cancer	0.00756	0.0177	CbGbCtD
Diclofenac—CYP1A2—Tamoxifen—pancreatic cancer	0.00698	0.0164	CbGbCtD
Diclofenac—CYP2C8—Fluorouracil—pancreatic cancer	0.00664	0.0156	CbGbCtD
Diclofenac—CYP2C9—Tamoxifen—pancreatic cancer	0.00629	0.0147	CbGbCtD
Diclofenac—ABCB1—Tamoxifen—pancreatic cancer	0.0061	0.0143	CbGbCtD
Diclofenac—CYP1A2—Erlotinib—pancreatic cancer	0.00593	0.0139	CbGbCtD
Diclofenac—ABCB1—Gemcitabine—pancreatic cancer	0.00525	0.0123	CbGbCtD
Diclofenac—ABCB1—Erlotinib—pancreatic cancer	0.00519	0.0122	CbGbCtD
Diclofenac—CYP1A2—Fluorouracil—pancreatic cancer	0.00514	0.0121	CbGbCtD
Diclofenac—CYP2B6—Doxorubicin—pancreatic cancer	0.00499	0.0117	CbGbCtD
Diclofenac—ABCB1—Irinotecan—pancreatic cancer	0.00468	0.011	CbGbCtD
Diclofenac—CYP2C9—Fluorouracil—pancreatic cancer	0.00463	0.0109	CbGbCtD
Diclofenac—CYP3A4—Tamoxifen—pancreatic cancer	0.00365	0.00857	CbGbCtD
Diclofenac—ABCB1—Docetaxel—pancreatic cancer	0.00343	0.00805	CbGbCtD
Diclofenac—ABCB1—Sunitinib—pancreatic cancer	0.00342	0.00801	CbGbCtD
Diclofenac—CYP3A4—Erlotinib—pancreatic cancer	0.00311	0.00728	CbGbCtD
Diclofenac—CYP3A4—Irinotecan—pancreatic cancer	0.00281	0.00658	CbGbCtD
Diclofenac—ABCB1—Doxorubicin—pancreatic cancer	0.00256	0.006	CbGbCtD
Diclofenac—CYP3A4—Docetaxel—pancreatic cancer	0.00206	0.00482	CbGbCtD
Diclofenac—CYP3A4—Sunitinib—pancreatic cancer	0.00205	0.0048	CbGbCtD
Diclofenac—CYP3A4—Doxorubicin—pancreatic cancer	0.00153	0.00359	CbGbCtD
Diclofenac—CXCL8—islet of Langerhans—pancreatic cancer	0.000581	0.0795	CbGeAlD
Diclofenac—TTR—islet of Langerhans—pancreatic cancer	0.000443	0.0607	CbGeAlD
Diclofenac—ALB—gall bladder—pancreatic cancer	0.000431	0.059	CbGeAlD
Diclofenac—Bromfenac—PTGS2—pancreatic cancer	0.000414	0.261	CrCbGaD
Diclofenac—PLA2G2A—pancreas—pancreatic cancer	0.000412	0.0565	CbGeAlD
Diclofenac—CXCL8—pancreas—pancreatic cancer	0.000408	0.0559	CbGeAlD
Diclofenac—ALOX5—islet of Langerhans—pancreatic cancer	0.000401	0.055	CbGeAlD
Diclofenac—PLA2G2A—digestive system—pancreatic cancer	0.000352	0.0482	CbGeAlD
Diclofenac—Lumiracoxib—PTGS2—pancreatic cancer	0.000352	0.222	CrCbGaD
Diclofenac—Nepafenac—PTGS2—pancreatic cancer	0.000335	0.211	CrCbGaD
Diclofenac—CYP2C18—digestive system—pancreatic cancer	0.000321	0.044	CbGeAlD
Diclofenac—TTR—pancreas—pancreatic cancer	0.000311	0.0426	CbGeAlD
Diclofenac—UGT2B7—digestive system—pancreatic cancer	0.000296	0.0406	CbGeAlD
Diclofenac—SLC22A11—digestive system—pancreatic cancer	0.000289	0.0396	CbGeAlD
Diclofenac—ALOX5—pancreas—pancreatic cancer	0.000282	0.0386	CbGeAlD
Diclofenac—Meclofenamic acid—PTGS2—pancreatic cancer	0.000274	0.173	CrCbGaD
Diclofenac—TTR—digestive system—pancreatic cancer	0.000266	0.0364	CbGeAlD
Diclofenac—UGT1A1—digestive system—pancreatic cancer	0.000252	0.0345	CbGeAlD
Diclofenac—ALOX5—digestive system—pancreatic cancer	0.000241	0.033	CbGeAlD
Diclofenac—PTGS2—gall bladder—pancreatic cancer	0.000235	0.0322	CbGeAlD
Diclofenac—Mefenamic acid—PTGS2—pancreatic cancer	0.000213	0.134	CrCbGaD
Diclofenac—ABCC4—pancreas—pancreatic cancer	0.000192	0.0263	CbGeAlD
Diclofenac—ABCC4—digestive system—pancreatic cancer	0.000164	0.0225	CbGeAlD
Diclofenac—PTGS2—islet of Langerhans—pancreatic cancer	0.000154	0.0211	CbGeAlD
Diclofenac—CYP2C19—digestive system—pancreatic cancer	0.000137	0.0187	CbGeAlD
Diclofenac—CYP1A2—digestive system—pancreatic cancer	0.000112	0.0153	CbGeAlD
Diclofenac—CYP1A1—digestive system—pancreatic cancer	0.00011	0.0151	CbGeAlD
Diclofenac—PTGS2—pancreas—pancreatic cancer	0.000108	0.0148	CbGeAlD
Diclofenac—CYP2B6—digestive system—pancreatic cancer	0.000107	0.0147	CbGeAlD
Diclofenac—CYP2C9—digestive system—pancreatic cancer	0.000106	0.0145	CbGeAlD
Diclofenac—CYP2E1—digestive system—pancreatic cancer	0.0001	0.0137	CbGeAlD
Diclofenac—PTGS1—digestive system—pancreatic cancer	9.67e-05	0.0132	CbGeAlD
Diclofenac—ABCB1—islet of Langerhans—pancreatic cancer	9.52e-05	0.013	CbGeAlD
Diclofenac—PTGS2—digestive system—pancreatic cancer	9.24e-05	0.0127	CbGeAlD
Diclofenac—CYP3A4—digestive system—pancreatic cancer	8.08e-05	0.0111	CbGeAlD
Diclofenac—ABCB1—pancreas—pancreatic cancer	6.7e-05	0.00917	CbGeAlD
Diclofenac—ABCB1—digestive system—pancreatic cancer	5.72e-05	0.00783	CbGeAlD
Diclofenac—Hyperglycaemia—Doxorubicin—pancreatic cancer	4.5e-05	0.000317	CcSEcCtD
Diclofenac—Diarrhoea—Irinotecan—pancreatic cancer	4.5e-05	0.000317	CcSEcCtD
Diclofenac—Agranulocytosis—Epirubicin—pancreatic cancer	4.49e-05	0.000316	CcSEcCtD
Diclofenac—Pneumonia—Doxorubicin—pancreatic cancer	4.48e-05	0.000315	CcSEcCtD
Diclofenac—Shock—Docetaxel—pancreatic cancer	4.48e-05	0.000315	CcSEcCtD
Diclofenac—Nervous system disorder—Docetaxel—pancreatic cancer	4.46e-05	0.000314	CcSEcCtD
Diclofenac—Pruritus—Fluorouracil—pancreatic cancer	4.46e-05	0.000314	CcSEcCtD
Diclofenac—Thrombocytopenia—Docetaxel—pancreatic cancer	4.45e-05	0.000313	CcSEcCtD
Diclofenac—Infestation—Doxorubicin—pancreatic cancer	4.45e-05	0.000313	CcSEcCtD
Diclofenac—Infestation NOS—Doxorubicin—pancreatic cancer	4.45e-05	0.000313	CcSEcCtD
Diclofenac—Drowsiness—Doxorubicin—pancreatic cancer	4.45e-05	0.000313	CcSEcCtD
Diclofenac—Tachycardia—Docetaxel—pancreatic cancer	4.44e-05	0.000312	CcSEcCtD
Diclofenac—Skin disorder—Docetaxel—pancreatic cancer	4.42e-05	0.000311	CcSEcCtD
Diclofenac—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	4.41e-05	0.000311	CcSEcCtD
Diclofenac—Bradycardia—Epirubicin—pancreatic cancer	4.4e-05	0.000309	CcSEcCtD
Diclofenac—Diarrhoea—Gemcitabine—pancreatic cancer	4.39e-05	0.000309	CcSEcCtD
Diclofenac—Renal failure—Doxorubicin—pancreatic cancer	4.38e-05	0.000308	CcSEcCtD
Diclofenac—Neuropathy peripheral—Doxorubicin—pancreatic cancer	4.36e-05	0.000307	CcSEcCtD
Diclofenac—Dizziness—Irinotecan—pancreatic cancer	4.35e-05	0.000306	CcSEcCtD
Diclofenac—Haemoglobin—Epirubicin—pancreatic cancer	4.34e-05	0.000305	CcSEcCtD
Diclofenac—Stomatitis—Doxorubicin—pancreatic cancer	4.34e-05	0.000305	CcSEcCtD
Diclofenac—Jaundice—Doxorubicin—pancreatic cancer	4.34e-05	0.000305	CcSEcCtD
Diclofenac—Anorexia—Docetaxel—pancreatic cancer	4.34e-05	0.000305	CcSEcCtD
Diclofenac—Rhinitis—Epirubicin—pancreatic cancer	4.33e-05	0.000305	CcSEcCtD
Diclofenac—Conjunctivitis—Doxorubicin—pancreatic cancer	4.33e-05	0.000305	CcSEcCtD
Diclofenac—Urinary tract infection—Doxorubicin—pancreatic cancer	4.33e-05	0.000305	CcSEcCtD
Diclofenac—Haemorrhage—Epirubicin—pancreatic cancer	4.32e-05	0.000304	CcSEcCtD
Diclofenac—Hepatitis—Epirubicin—pancreatic cancer	4.32e-05	0.000304	CcSEcCtD
Diclofenac—Diarrhoea—Fluorouracil—pancreatic cancer	4.31e-05	0.000304	CcSEcCtD
Diclofenac—Hypoaesthesia—Epirubicin—pancreatic cancer	4.3e-05	0.000302	CcSEcCtD
Diclofenac—Pharyngitis—Epirubicin—pancreatic cancer	4.29e-05	0.000302	CcSEcCtD
Diclofenac—Sweating—Doxorubicin—pancreatic cancer	4.27e-05	0.0003	CcSEcCtD
Diclofenac—Urinary tract disorder—Epirubicin—pancreatic cancer	4.26e-05	0.0003	CcSEcCtD
Diclofenac—Oedema peripheral—Epirubicin—pancreatic cancer	4.25e-05	0.000299	CcSEcCtD
Diclofenac—Hypotension—Docetaxel—pancreatic cancer	4.25e-05	0.000299	CcSEcCtD
Diclofenac—Haematuria—Doxorubicin—pancreatic cancer	4.24e-05	0.000299	CcSEcCtD
Diclofenac—Urethral disorder—Epirubicin—pancreatic cancer	4.23e-05	0.000298	CcSEcCtD
Diclofenac—Hepatobiliary disease—Doxorubicin—pancreatic cancer	4.21e-05	0.000296	CcSEcCtD
Diclofenac—Epistaxis—Doxorubicin—pancreatic cancer	4.2e-05	0.000295	CcSEcCtD
Diclofenac—Vomiting—Irinotecan—pancreatic cancer	4.18e-05	0.000294	CcSEcCtD
Diclofenac—Sinusitis—Doxorubicin—pancreatic cancer	4.18e-05	0.000294	CcSEcCtD
Diclofenac—Dizziness—Fluorouracil—pancreatic cancer	4.17e-05	0.000293	CcSEcCtD
Diclofenac—Visual impairment—Epirubicin—pancreatic cancer	4.16e-05	0.000293	CcSEcCtD
Diclofenac—Agranulocytosis—Doxorubicin—pancreatic cancer	4.15e-05	0.000292	CcSEcCtD
Diclofenac—Rash—Irinotecan—pancreatic cancer	4.15e-05	0.000292	CcSEcCtD
Diclofenac—Dermatitis—Irinotecan—pancreatic cancer	4.15e-05	0.000292	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	4.14e-05	0.000292	CcSEcCtD
Diclofenac—Headache—Irinotecan—pancreatic cancer	4.12e-05	0.00029	CcSEcCtD
Diclofenac—Insomnia—Docetaxel—pancreatic cancer	4.11e-05	0.00029	CcSEcCtD
Diclofenac—Paraesthesia—Docetaxel—pancreatic cancer	4.08e-05	0.000287	CcSEcCtD
Diclofenac—Erythema multiforme—Epirubicin—pancreatic cancer	4.08e-05	0.000287	CcSEcCtD
Diclofenac—Vomiting—Gemcitabine—pancreatic cancer	4.08e-05	0.000287	CcSEcCtD
Diclofenac—Bradycardia—Doxorubicin—pancreatic cancer	4.07e-05	0.000286	CcSEcCtD
Diclofenac—Dyspnoea—Docetaxel—pancreatic cancer	4.06e-05	0.000285	CcSEcCtD
Diclofenac—Somnolence—Docetaxel—pancreatic cancer	4.04e-05	0.000285	CcSEcCtD
Diclofenac—Rash—Gemcitabine—pancreatic cancer	4.04e-05	0.000284	CcSEcCtD
Diclofenac—Dermatitis—Gemcitabine—pancreatic cancer	4.04e-05	0.000284	CcSEcCtD
Diclofenac—Eye disorder—Epirubicin—pancreatic cancer	4.04e-05	0.000284	CcSEcCtD
Diclofenac—Tinnitus—Epirubicin—pancreatic cancer	4.03e-05	0.000283	CcSEcCtD
Diclofenac—Haemoglobin—Doxorubicin—pancreatic cancer	4.02e-05	0.000283	CcSEcCtD
Diclofenac—Headache—Gemcitabine—pancreatic cancer	4.02e-05	0.000283	CcSEcCtD
Diclofenac—Cardiac disorder—Epirubicin—pancreatic cancer	4.01e-05	0.000282	CcSEcCtD
Diclofenac—Flushing—Epirubicin—pancreatic cancer	4.01e-05	0.000282	CcSEcCtD
Diclofenac—Vomiting—Fluorouracil—pancreatic cancer	4.01e-05	0.000282	CcSEcCtD
Diclofenac—Rhinitis—Doxorubicin—pancreatic cancer	4.01e-05	0.000282	CcSEcCtD
Diclofenac—Dyspepsia—Docetaxel—pancreatic cancer	4e-05	0.000282	CcSEcCtD
Diclofenac—Hepatitis—Doxorubicin—pancreatic cancer	4e-05	0.000281	CcSEcCtD
Diclofenac—Haemorrhage—Doxorubicin—pancreatic cancer	4e-05	0.000281	CcSEcCtD
Diclofenac—Hypoaesthesia—Doxorubicin—pancreatic cancer	3.98e-05	0.00028	CcSEcCtD
Diclofenac—Rash—Fluorouracil—pancreatic cancer	3.97e-05	0.00028	CcSEcCtD
Diclofenac—Dermatitis—Fluorouracil—pancreatic cancer	3.97e-05	0.000279	CcSEcCtD
Diclofenac—Pharyngitis—Doxorubicin—pancreatic cancer	3.97e-05	0.000279	CcSEcCtD
Diclofenac—Decreased appetite—Docetaxel—pancreatic cancer	3.95e-05	0.000278	CcSEcCtD
Diclofenac—Headache—Fluorouracil—pancreatic cancer	3.95e-05	0.000278	CcSEcCtD
Diclofenac—Urinary tract disorder—Doxorubicin—pancreatic cancer	3.95e-05	0.000278	CcSEcCtD
Diclofenac—Oedema peripheral—Doxorubicin—pancreatic cancer	3.94e-05	0.000277	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Docetaxel—pancreatic cancer	3.93e-05	0.000276	CcSEcCtD
Diclofenac—Fatigue—Docetaxel—pancreatic cancer	3.92e-05	0.000276	CcSEcCtD
Diclofenac—Angiopathy—Epirubicin—pancreatic cancer	3.92e-05	0.000276	CcSEcCtD
Diclofenac—Urethral disorder—Doxorubicin—pancreatic cancer	3.92e-05	0.000276	CcSEcCtD
Diclofenac—Nausea—Irinotecan—pancreatic cancer	3.91e-05	0.000275	CcSEcCtD
Diclofenac—Immune system disorder—Epirubicin—pancreatic cancer	3.9e-05	0.000275	CcSEcCtD
Diclofenac—Mediastinal disorder—Epirubicin—pancreatic cancer	3.89e-05	0.000274	CcSEcCtD
Diclofenac—Pain—Docetaxel—pancreatic cancer	3.89e-05	0.000274	CcSEcCtD
Diclofenac—Constipation—Docetaxel—pancreatic cancer	3.89e-05	0.000274	CcSEcCtD
Diclofenac—Chills—Epirubicin—pancreatic cancer	3.87e-05	0.000273	CcSEcCtD
Diclofenac—Arrhythmia—Epirubicin—pancreatic cancer	3.86e-05	0.000272	CcSEcCtD
Diclofenac—Visual impairment—Doxorubicin—pancreatic cancer	3.85e-05	0.000271	CcSEcCtD
Diclofenac—Alopecia—Epirubicin—pancreatic cancer	3.82e-05	0.000269	CcSEcCtD
Diclofenac—Nausea—Gemcitabine—pancreatic cancer	3.81e-05	0.000268	CcSEcCtD
Diclofenac—Mental disorder—Epirubicin—pancreatic cancer	3.78e-05	0.000266	CcSEcCtD
Diclofenac—Erythema multiforme—Doxorubicin—pancreatic cancer	3.78e-05	0.000266	CcSEcCtD
Diclofenac—Malnutrition—Epirubicin—pancreatic cancer	3.76e-05	0.000265	CcSEcCtD
Diclofenac—Erythema—Epirubicin—pancreatic cancer	3.76e-05	0.000265	CcSEcCtD
Diclofenac—Feeling abnormal—Docetaxel—pancreatic cancer	3.75e-05	0.000264	CcSEcCtD
Diclofenac—Nausea—Fluorouracil—pancreatic cancer	3.74e-05	0.000263	CcSEcCtD
Diclofenac—Eye disorder—Doxorubicin—pancreatic cancer	3.73e-05	0.000263	CcSEcCtD
Diclofenac—Tinnitus—Doxorubicin—pancreatic cancer	3.73e-05	0.000262	CcSEcCtD
Diclofenac—Gastrointestinal pain—Docetaxel—pancreatic cancer	3.72e-05	0.000262	CcSEcCtD
Diclofenac—Cardiac disorder—Doxorubicin—pancreatic cancer	3.71e-05	0.000261	CcSEcCtD
Diclofenac—Flushing—Doxorubicin—pancreatic cancer	3.71e-05	0.000261	CcSEcCtD
Diclofenac—Flatulence—Epirubicin—pancreatic cancer	3.7e-05	0.000261	CcSEcCtD
Diclofenac—Tension—Epirubicin—pancreatic cancer	3.69e-05	0.00026	CcSEcCtD
Diclofenac—Dysgeusia—Epirubicin—pancreatic cancer	3.68e-05	0.000259	CcSEcCtD
Diclofenac—Nervousness—Epirubicin—pancreatic cancer	3.65e-05	0.000257	CcSEcCtD
Diclofenac—Back pain—Epirubicin—pancreatic cancer	3.64e-05	0.000256	CcSEcCtD
Diclofenac—Angiopathy—Doxorubicin—pancreatic cancer	3.63e-05	0.000255	CcSEcCtD
Diclofenac—Muscle spasms—Epirubicin—pancreatic cancer	3.61e-05	0.000254	CcSEcCtD
Diclofenac—Immune system disorder—Doxorubicin—pancreatic cancer	3.61e-05	0.000254	CcSEcCtD
Diclofenac—Mediastinal disorder—Doxorubicin—pancreatic cancer	3.6e-05	0.000253	CcSEcCtD
Diclofenac—Abdominal pain—Docetaxel—pancreatic cancer	3.6e-05	0.000253	CcSEcCtD
Diclofenac—Body temperature increased—Docetaxel—pancreatic cancer	3.6e-05	0.000253	CcSEcCtD
Diclofenac—Chills—Doxorubicin—pancreatic cancer	3.59e-05	0.000252	CcSEcCtD
Diclofenac—Arrhythmia—Doxorubicin—pancreatic cancer	3.57e-05	0.000251	CcSEcCtD
Diclofenac—Vision blurred—Epirubicin—pancreatic cancer	3.54e-05	0.000249	CcSEcCtD
Diclofenac—Alopecia—Doxorubicin—pancreatic cancer	3.53e-05	0.000249	CcSEcCtD
Diclofenac—Mental disorder—Doxorubicin—pancreatic cancer	3.5e-05	0.000246	CcSEcCtD
Diclofenac—Ill-defined disorder—Epirubicin—pancreatic cancer	3.49e-05	0.000246	CcSEcCtD
Diclofenac—Malnutrition—Doxorubicin—pancreatic cancer	3.48e-05	0.000245	CcSEcCtD
Diclofenac—Erythema—Doxorubicin—pancreatic cancer	3.48e-05	0.000245	CcSEcCtD
Diclofenac—Anaemia—Epirubicin—pancreatic cancer	3.47e-05	0.000245	CcSEcCtD
Diclofenac—Agitation—Epirubicin—pancreatic cancer	3.45e-05	0.000243	CcSEcCtD
Diclofenac—Flatulence—Doxorubicin—pancreatic cancer	3.43e-05	0.000241	CcSEcCtD
Diclofenac—Tension—Doxorubicin—pancreatic cancer	3.41e-05	0.00024	CcSEcCtD
Diclofenac—Dysgeusia—Doxorubicin—pancreatic cancer	3.41e-05	0.00024	CcSEcCtD
Diclofenac—Malaise—Epirubicin—pancreatic cancer	3.39e-05	0.000239	CcSEcCtD
Diclofenac—Nervousness—Doxorubicin—pancreatic cancer	3.38e-05	0.000238	CcSEcCtD
Diclofenac—Vertigo—Epirubicin—pancreatic cancer	3.38e-05	0.000238	CcSEcCtD
Diclofenac—Syncope—Epirubicin—pancreatic cancer	3.37e-05	0.000237	CcSEcCtD
Diclofenac—Leukopenia—Epirubicin—pancreatic cancer	3.37e-05	0.000237	CcSEcCtD
Diclofenac—Back pain—Doxorubicin—pancreatic cancer	3.36e-05	0.000237	CcSEcCtD
Diclofenac—Hypersensitivity—Docetaxel—pancreatic cancer	3.35e-05	0.000236	CcSEcCtD
Diclofenac—Muscle spasms—Doxorubicin—pancreatic cancer	3.34e-05	0.000235	CcSEcCtD
Diclofenac—Palpitations—Epirubicin—pancreatic cancer	3.32e-05	0.000234	CcSEcCtD
Diclofenac—Loss of consciousness—Epirubicin—pancreatic cancer	3.3e-05	0.000233	CcSEcCtD
Diclofenac—Cough—Epirubicin—pancreatic cancer	3.28e-05	0.000231	CcSEcCtD
Diclofenac—Vision blurred—Doxorubicin—pancreatic cancer	3.28e-05	0.000231	CcSEcCtD
Diclofenac—Asthenia—Docetaxel—pancreatic cancer	3.26e-05	0.00023	CcSEcCtD
Diclofenac—Convulsion—Epirubicin—pancreatic cancer	3.26e-05	0.000229	CcSEcCtD
Diclofenac—Hypertension—Epirubicin—pancreatic cancer	3.25e-05	0.000228	CcSEcCtD
Diclofenac—Ill-defined disorder—Doxorubicin—pancreatic cancer	3.23e-05	0.000227	CcSEcCtD
Diclofenac—Pruritus—Docetaxel—pancreatic cancer	3.22e-05	0.000227	CcSEcCtD
Diclofenac—Anaemia—Doxorubicin—pancreatic cancer	3.21e-05	0.000226	CcSEcCtD
Diclofenac—Arthralgia—Epirubicin—pancreatic cancer	3.2e-05	0.000225	CcSEcCtD
Diclofenac—Chest pain—Epirubicin—pancreatic cancer	3.2e-05	0.000225	CcSEcCtD
Diclofenac—Myalgia—Epirubicin—pancreatic cancer	3.2e-05	0.000225	CcSEcCtD
Diclofenac—Agitation—Doxorubicin—pancreatic cancer	3.2e-05	0.000225	CcSEcCtD
Diclofenac—Anxiety—Epirubicin—pancreatic cancer	3.19e-05	0.000224	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	3.18e-05	0.000224	CcSEcCtD
Diclofenac—Discomfort—Epirubicin—pancreatic cancer	3.16e-05	0.000223	CcSEcCtD
Diclofenac—Malaise—Doxorubicin—pancreatic cancer	3.14e-05	0.000221	CcSEcCtD
Diclofenac—Dry mouth—Epirubicin—pancreatic cancer	3.13e-05	0.00022	CcSEcCtD
Diclofenac—Vertigo—Doxorubicin—pancreatic cancer	3.13e-05	0.00022	CcSEcCtD
Diclofenac—Syncope—Doxorubicin—pancreatic cancer	3.12e-05	0.00022	CcSEcCtD
Diclofenac—Leukopenia—Doxorubicin—pancreatic cancer	3.11e-05	0.000219	CcSEcCtD
Diclofenac—Diarrhoea—Docetaxel—pancreatic cancer	3.11e-05	0.000219	CcSEcCtD
Diclofenac—Confusional state—Epirubicin—pancreatic cancer	3.09e-05	0.000218	CcSEcCtD
Diclofenac—Palpitations—Doxorubicin—pancreatic cancer	3.07e-05	0.000216	CcSEcCtD
Diclofenac—Oedema—Epirubicin—pancreatic cancer	3.07e-05	0.000216	CcSEcCtD
Diclofenac—Anaphylactic shock—Epirubicin—pancreatic cancer	3.07e-05	0.000216	CcSEcCtD
Diclofenac—Loss of consciousness—Doxorubicin—pancreatic cancer	3.06e-05	0.000215	CcSEcCtD
Diclofenac—Infection—Epirubicin—pancreatic cancer	3.05e-05	0.000215	CcSEcCtD
Diclofenac—Cough—Doxorubicin—pancreatic cancer	3.04e-05	0.000214	CcSEcCtD
Diclofenac—Shock—Epirubicin—pancreatic cancer	3.02e-05	0.000212	CcSEcCtD
Diclofenac—Convulsion—Doxorubicin—pancreatic cancer	3.01e-05	0.000212	CcSEcCtD
Diclofenac—Nervous system disorder—Epirubicin—pancreatic cancer	3.01e-05	0.000212	CcSEcCtD
Diclofenac—Dizziness—Docetaxel—pancreatic cancer	3.01e-05	0.000212	CcSEcCtD
Diclofenac—Thrombocytopenia—Epirubicin—pancreatic cancer	3e-05	0.000211	CcSEcCtD
Diclofenac—Hypertension—Doxorubicin—pancreatic cancer	3e-05	0.000211	CcSEcCtD
Diclofenac—Tachycardia—Epirubicin—pancreatic cancer	2.99e-05	0.000211	CcSEcCtD
Diclofenac—Skin disorder—Epirubicin—pancreatic cancer	2.98e-05	0.00021	CcSEcCtD
Diclofenac—Hyperhidrosis—Epirubicin—pancreatic cancer	2.97e-05	0.000209	CcSEcCtD
Diclofenac—Myalgia—Doxorubicin—pancreatic cancer	2.96e-05	0.000208	CcSEcCtD
Diclofenac—Chest pain—Doxorubicin—pancreatic cancer	2.96e-05	0.000208	CcSEcCtD
Diclofenac—Arthralgia—Doxorubicin—pancreatic cancer	2.96e-05	0.000208	CcSEcCtD
Diclofenac—Anxiety—Doxorubicin—pancreatic cancer	2.95e-05	0.000208	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	2.94e-05	0.000207	CcSEcCtD
Diclofenac—Discomfort—Doxorubicin—pancreatic cancer	2.93e-05	0.000206	CcSEcCtD
Diclofenac—Anorexia—Epirubicin—pancreatic cancer	2.92e-05	0.000206	CcSEcCtD
Diclofenac—Dry mouth—Doxorubicin—pancreatic cancer	2.9e-05	0.000204	CcSEcCtD
Diclofenac—Vomiting—Docetaxel—pancreatic cancer	2.89e-05	0.000204	CcSEcCtD
Diclofenac—Rash—Docetaxel—pancreatic cancer	2.87e-05	0.000202	CcSEcCtD
Diclofenac—Hypotension—Epirubicin—pancreatic cancer	2.87e-05	0.000202	CcSEcCtD
Diclofenac—Dermatitis—Docetaxel—pancreatic cancer	2.87e-05	0.000202	CcSEcCtD
Diclofenac—Confusional state—Doxorubicin—pancreatic cancer	2.86e-05	0.000201	CcSEcCtD
Diclofenac—Headache—Docetaxel—pancreatic cancer	2.85e-05	0.000201	CcSEcCtD
Diclofenac—Anaphylactic shock—Doxorubicin—pancreatic cancer	2.84e-05	0.0002	CcSEcCtD
Diclofenac—Oedema—Doxorubicin—pancreatic cancer	2.84e-05	0.0002	CcSEcCtD
Diclofenac—Infection—Doxorubicin—pancreatic cancer	2.82e-05	0.000199	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	2.8e-05	0.000197	CcSEcCtD
Diclofenac—Shock—Doxorubicin—pancreatic cancer	2.79e-05	0.000197	CcSEcCtD
Diclofenac—Nervous system disorder—Doxorubicin—pancreatic cancer	2.78e-05	0.000196	CcSEcCtD
Diclofenac—Thrombocytopenia—Doxorubicin—pancreatic cancer	2.78e-05	0.000196	CcSEcCtD
Diclofenac—Insomnia—Epirubicin—pancreatic cancer	2.77e-05	0.000195	CcSEcCtD
Diclofenac—Tachycardia—Doxorubicin—pancreatic cancer	2.77e-05	0.000195	CcSEcCtD
Diclofenac—Skin disorder—Doxorubicin—pancreatic cancer	2.76e-05	0.000194	CcSEcCtD
Diclofenac—Paraesthesia—Epirubicin—pancreatic cancer	2.76e-05	0.000194	CcSEcCtD
Diclofenac—Hyperhidrosis—Doxorubicin—pancreatic cancer	2.74e-05	0.000193	CcSEcCtD
Diclofenac—Dyspnoea—Epirubicin—pancreatic cancer	2.74e-05	0.000193	CcSEcCtD
Diclofenac—Somnolence—Epirubicin—pancreatic cancer	2.73e-05	0.000192	CcSEcCtD
Diclofenac—Anorexia—Doxorubicin—pancreatic cancer	2.71e-05	0.00019	CcSEcCtD
Diclofenac—Nausea—Docetaxel—pancreatic cancer	2.7e-05	0.00019	CcSEcCtD
Diclofenac—Dyspepsia—Epirubicin—pancreatic cancer	2.7e-05	0.00019	CcSEcCtD
Diclofenac—Decreased appetite—Epirubicin—pancreatic cancer	2.67e-05	0.000188	CcSEcCtD
Diclofenac—Hypotension—Doxorubicin—pancreatic cancer	2.65e-05	0.000187	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Epirubicin—pancreatic cancer	2.65e-05	0.000186	CcSEcCtD
Diclofenac—Fatigue—Epirubicin—pancreatic cancer	2.65e-05	0.000186	CcSEcCtD
Diclofenac—Constipation—Epirubicin—pancreatic cancer	2.62e-05	0.000185	CcSEcCtD
Diclofenac—Pain—Epirubicin—pancreatic cancer	2.62e-05	0.000185	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	2.59e-05	0.000182	CcSEcCtD
Diclofenac—Insomnia—Doxorubicin—pancreatic cancer	2.57e-05	0.000181	CcSEcCtD
Diclofenac—Paraesthesia—Doxorubicin—pancreatic cancer	2.55e-05	0.000179	CcSEcCtD
Diclofenac—Dyspnoea—Doxorubicin—pancreatic cancer	2.53e-05	0.000178	CcSEcCtD
Diclofenac—Feeling abnormal—Epirubicin—pancreatic cancer	2.53e-05	0.000178	CcSEcCtD
Diclofenac—Somnolence—Doxorubicin—pancreatic cancer	2.52e-05	0.000178	CcSEcCtD
Diclofenac—Gastrointestinal pain—Epirubicin—pancreatic cancer	2.51e-05	0.000177	CcSEcCtD
Diclofenac—Dyspepsia—Doxorubicin—pancreatic cancer	2.5e-05	0.000176	CcSEcCtD
Diclofenac—Decreased appetite—Doxorubicin—pancreatic cancer	2.47e-05	0.000174	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	2.45e-05	0.000173	CcSEcCtD
Diclofenac—Fatigue—Doxorubicin—pancreatic cancer	2.45e-05	0.000172	CcSEcCtD
Diclofenac—Urticaria—Epirubicin—pancreatic cancer	2.44e-05	0.000172	CcSEcCtD
Diclofenac—Pain—Doxorubicin—pancreatic cancer	2.43e-05	0.000171	CcSEcCtD
Diclofenac—Constipation—Doxorubicin—pancreatic cancer	2.43e-05	0.000171	CcSEcCtD
Diclofenac—Abdominal pain—Epirubicin—pancreatic cancer	2.43e-05	0.000171	CcSEcCtD
Diclofenac—Body temperature increased—Epirubicin—pancreatic cancer	2.43e-05	0.000171	CcSEcCtD
Diclofenac—Feeling abnormal—Doxorubicin—pancreatic cancer	2.34e-05	0.000165	CcSEcCtD
Diclofenac—Gastrointestinal pain—Doxorubicin—pancreatic cancer	2.32e-05	0.000163	CcSEcCtD
Diclofenac—Hypersensitivity—Epirubicin—pancreatic cancer	2.26e-05	0.000159	CcSEcCtD
Diclofenac—Urticaria—Doxorubicin—pancreatic cancer	2.26e-05	0.000159	CcSEcCtD
Diclofenac—Abdominal pain—Doxorubicin—pancreatic cancer	2.24e-05	0.000158	CcSEcCtD
Diclofenac—Body temperature increased—Doxorubicin—pancreatic cancer	2.24e-05	0.000158	CcSEcCtD
Diclofenac—Asthenia—Epirubicin—pancreatic cancer	2.2e-05	0.000155	CcSEcCtD
Diclofenac—Pruritus—Epirubicin—pancreatic cancer	2.17e-05	0.000153	CcSEcCtD
Diclofenac—Diarrhoea—Epirubicin—pancreatic cancer	2.1e-05	0.000148	CcSEcCtD
Diclofenac—Hypersensitivity—Doxorubicin—pancreatic cancer	2.09e-05	0.000147	CcSEcCtD
Diclofenac—Asthenia—Doxorubicin—pancreatic cancer	2.04e-05	0.000143	CcSEcCtD
Diclofenac—Dizziness—Epirubicin—pancreatic cancer	2.03e-05	0.000143	CcSEcCtD
Diclofenac—Pruritus—Doxorubicin—pancreatic cancer	2.01e-05	0.000141	CcSEcCtD
Diclofenac—Vomiting—Epirubicin—pancreatic cancer	1.95e-05	0.000137	CcSEcCtD
Diclofenac—Diarrhoea—Doxorubicin—pancreatic cancer	1.94e-05	0.000137	CcSEcCtD
Diclofenac—Rash—Epirubicin—pancreatic cancer	1.93e-05	0.000136	CcSEcCtD
Diclofenac—Dermatitis—Epirubicin—pancreatic cancer	1.93e-05	0.000136	CcSEcCtD
Diclofenac—Headache—Epirubicin—pancreatic cancer	1.92e-05	0.000135	CcSEcCtD
Diclofenac—Dizziness—Doxorubicin—pancreatic cancer	1.88e-05	0.000132	CcSEcCtD
Diclofenac—Nausea—Epirubicin—pancreatic cancer	1.82e-05	0.000128	CcSEcCtD
Diclofenac—Vomiting—Doxorubicin—pancreatic cancer	1.8e-05	0.000127	CcSEcCtD
Diclofenac—Rash—Doxorubicin—pancreatic cancer	1.79e-05	0.000126	CcSEcCtD
Diclofenac—Dermatitis—Doxorubicin—pancreatic cancer	1.79e-05	0.000126	CcSEcCtD
Diclofenac—Headache—Doxorubicin—pancreatic cancer	1.78e-05	0.000125	CcSEcCtD
Diclofenac—Nausea—Doxorubicin—pancreatic cancer	1.69e-05	0.000119	CcSEcCtD
Diclofenac—ABCC1—Disease—PIK3CB—pancreatic cancer	4.11e-06	5.32e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GCG—pancreatic cancer	4.11e-06	5.32e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—TYMS—pancreatic cancer	4.11e-06	5.32e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PIK3CD—pancreatic cancer	4.1e-06	5.3e-05	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—AKT1—pancreatic cancer	4.09e-06	5.3e-05	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—PIK3CA—pancreatic cancer	4.09e-06	5.3e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—HIF1A—pancreatic cancer	4.09e-06	5.29e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—DPYD—pancreatic cancer	4.08e-06	5.28e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—TSC2—pancreatic cancer	4.08e-06	5.28e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PTGS2—pancreatic cancer	4.07e-06	5.27e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CASP3—pancreatic cancer	4.06e-06	5.25e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—PIK3CA—pancreatic cancer	4.01e-06	5.19e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—APOE—pancreatic cancer	3.99e-06	5.16e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.98e-06	5.16e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.98e-06	5.15e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—TYMP—pancreatic cancer	3.97e-06	5.14e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PIK3CD—pancreatic cancer	3.95e-06	5.11e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CCND1—pancreatic cancer	3.95e-06	5.11e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—TYMS—pancreatic cancer	3.95e-06	5.11e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.94e-06	5.1e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CTNNB1—pancreatic cancer	3.91e-06	5.06e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PTEN—pancreatic cancer	3.9e-06	5.05e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—STK11—pancreatic cancer	3.89e-06	5.03e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TP53—pancreatic cancer	3.88e-06	5.02e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	3.87e-06	5.01e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—TYMS—pancreatic cancer	3.87e-06	5.01e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—STK11—pancreatic cancer	3.86e-06	5e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CD44—pancreatic cancer	3.85e-06	4.98e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MMP9—pancreatic cancer	3.83e-06	4.96e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.83e-06	4.96e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PTEN—pancreatic cancer	3.81e-06	4.93e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CG—pancreatic cancer	3.8e-06	4.92e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PTEN—pancreatic cancer	3.8e-06	4.91e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.77e-06	4.88e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CD44—pancreatic cancer	3.76e-06	4.86e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.73e-06	4.83e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—AKT1—pancreatic cancer	3.72e-06	4.81e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—HRAS—pancreatic cancer	3.71e-06	4.8e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.7e-06	4.79e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—SRC—pancreatic cancer	3.69e-06	4.78e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GCG—pancreatic cancer	3.69e-06	4.77e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—NOTCH1—pancreatic cancer	3.68e-06	4.77e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PPARG—pancreatic cancer	3.67e-06	4.74e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.65e-06	4.72e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—TYMS—pancreatic cancer	3.65e-06	4.72e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—CTNNB1—pancreatic cancer	3.64e-06	4.72e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.63e-06	4.69e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GCG—pancreatic cancer	3.6e-06	4.66e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—VEGFA—pancreatic cancer	3.6e-06	4.66e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PIK3CB—pancreatic cancer	3.57e-06	4.62e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—EGF—pancreatic cancer	3.56e-06	4.61e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—NRAS—pancreatic cancer	3.55e-06	4.6e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PTEN—pancreatic cancer	3.55e-06	4.6e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PTGS2—pancreatic cancer	3.54e-06	4.58e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—SRC—pancreatic cancer	3.53e-06	4.57e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CD44—pancreatic cancer	3.51e-06	4.54e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—STK11—pancreatic cancer	3.47e-06	4.49e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PIK3CB—pancreatic cancer	3.44e-06	4.46e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—VEGFA—pancreatic cancer	3.44e-06	4.46e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.44e-06	4.45e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PTGS2—pancreatic cancer	3.41e-06	4.41e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—STAT3—pancreatic cancer	3.41e-06	4.41e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.4e-06	4.41e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—NRAS—pancreatic cancer	3.4e-06	4.4e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—STK11—pancreatic cancer	3.39e-06	4.38e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.37e-06	4.36e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GCG—pancreatic cancer	3.36e-06	4.35e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—TYMS—pancreatic cancer	3.34e-06	4.33e-05	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—AKT1—pancreatic cancer	3.34e-06	4.33e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—APOE—pancreatic cancer	3.34e-06	4.32e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CD—pancreatic cancer	3.34e-06	4.32e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—TYMS—pancreatic cancer	3.32e-06	4.3e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TGFB1—pancreatic cancer	3.3e-06	4.27e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—SRC—pancreatic cancer	3.29e-06	4.26e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—AKT1—pancreatic cancer	3.27e-06	4.24e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.26e-06	4.21e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—APOE—pancreatic cancer	3.21e-06	4.16e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GLP1R—pancreatic cancer	3.2e-06	4.14e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—STAT3—pancreatic cancer	3.18e-06	4.11e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—NRAS—pancreatic cancer	3.17e-06	4.1e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MYC—pancreatic cancer	3.17e-06	4.1e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CD—pancreatic cancer	3.17e-06	4.1e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—STK11—pancreatic cancer	3.16e-06	4.09e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.16e-06	4.09e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TGFB1—pancreatic cancer	3.16e-06	4.09e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—DPYD—pancreatic cancer	3.15e-06	4.08e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—APOE—pancreatic cancer	3.15e-06	4.07e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—EGFR—pancreatic cancer	3.1e-06	4.01e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PTEN—pancreatic cancer	3.09e-06	3.99e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—KRAS—pancreatic cancer	3.06e-06	3.96e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CG—pancreatic cancer	3.02e-06	3.9e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CD44—pancreatic cancer	3e-06	3.88e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	2.99e-06	3.87e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—TYMS—pancreatic cancer	2.98e-06	3.86e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PTEN—pancreatic cancer	2.97e-06	3.85e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.97e-06	3.84e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—APOE—pancreatic cancer	2.97e-06	3.84e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MYC—pancreatic cancer	2.95e-06	3.82e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—TGFB1—pancreatic cancer	2.94e-06	3.81e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.94e-06	3.8e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—KRAS—pancreatic cancer	2.93e-06	3.79e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—TYMS—pancreatic cancer	2.91e-06	3.77e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CB—pancreatic cancer	2.91e-06	3.77e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PPARG—pancreatic cancer	2.91e-06	3.77e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.91e-06	3.76e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CG—pancreatic cancer	2.9e-06	3.75e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—EGFR—pancreatic cancer	2.89e-06	3.74e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PTGS2—pancreatic cancer	2.88e-06	3.73e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GCG—pancreatic cancer	2.87e-06	3.72e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CG—pancreatic cancer	2.84e-06	3.67e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—PIK3CA—pancreatic cancer	2.81e-06	3.64e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.81e-06	3.63e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PPARG—pancreatic cancer	2.8e-06	3.62e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CB—pancreatic cancer	2.76e-06	3.57e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PIK3CA—pancreatic cancer	2.75e-06	3.56e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PPARG—pancreatic cancer	2.74e-06	3.55e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—KRAS—pancreatic cancer	2.73e-06	3.53e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—TYMS—pancreatic cancer	2.72e-06	3.52e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TP53—pancreatic cancer	2.72e-06	3.52e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—APOE—pancreatic cancer	2.72e-06	3.52e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—APOE—pancreatic cancer	2.7e-06	3.5e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—STK11—pancreatic cancer	2.7e-06	3.5e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PIK3CA—pancreatic cancer	2.69e-06	3.48e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PIK3CA—pancreatic cancer	2.68e-06	3.47e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CG—pancreatic cancer	2.68e-06	3.46e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CD—pancreatic cancer	2.65e-06	3.43e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TP53—pancreatic cancer	2.6e-06	3.37e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—HRAS—pancreatic cancer	2.6e-06	3.37e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PPARG—pancreatic cancer	2.58e-06	3.34e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.57e-06	3.33e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.56e-06	3.31e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CD—pancreatic cancer	2.55e-06	3.3e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.54e-06	3.28e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PTEN—pancreatic cancer	2.51e-06	3.26e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PIK3CA—pancreatic cancer	2.51e-06	3.24e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CD—pancreatic cancer	2.5e-06	3.23e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—HRAS—pancreatic cancer	2.49e-06	3.22e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	2.45e-06	3.18e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CTNNB1—pancreatic cancer	2.45e-06	3.17e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CG—pancreatic cancer	2.44e-06	3.16e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—APOE—pancreatic cancer	2.43e-06	3.14e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PTEN—pancreatic cancer	2.38e-06	3.09e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—APOE—pancreatic cancer	2.37e-06	3.07e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PPARG—pancreatic cancer	2.37e-06	3.06e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PPARG—pancreatic cancer	2.35e-06	3.05e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CD—pancreatic cancer	2.35e-06	3.04e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—TYMS—pancreatic cancer	2.32e-06	3.01e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—HRAS—pancreatic cancer	2.32e-06	3e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CD44—pancreatic cancer	2.31e-06	2.99e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CB—pancreatic cancer	2.31e-06	2.99e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.3e-06	2.97e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—AKT1—pancreatic cancer	2.3e-06	2.97e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—AKT1—pancreatic cancer	2.25e-06	2.91e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CB—pancreatic cancer	2.22e-06	2.87e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GCG—pancreatic cancer	2.22e-06	2.87e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—APOE—pancreatic cancer	2.21e-06	2.86e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—SRC—pancreatic cancer	2.21e-06	2.86e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PTGS2—pancreatic cancer	2.2e-06	2.85e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—AKT1—pancreatic cancer	2.2e-06	2.84e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	2.19e-06	2.83e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—AKT1—pancreatic cancer	2.19e-06	2.83e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PIK3CA—pancreatic cancer	2.18e-06	2.82e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CB—pancreatic cancer	2.17e-06	2.81e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	2.16e-06	2.79e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PTGS2—pancreatic cancer	2.16e-06	2.79e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CD—pancreatic cancer	2.14e-06	2.78e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CG—pancreatic cancer	2.14e-06	2.77e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—STAT3—pancreatic cancer	2.13e-06	2.76e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—NRAS—pancreatic cancer	2.13e-06	2.75e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PPARG—pancreatic cancer	2.11e-06	2.74e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PIK3CA—pancreatic cancer	2.1e-06	2.72e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.09e-06	2.71e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—STK11—pancreatic cancer	2.09e-06	2.7e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PPARG—pancreatic cancer	2.06e-06	2.67e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CB—pancreatic cancer	2.05e-06	2.65e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—AKT1—pancreatic cancer	2.05e-06	2.65e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PTGS2—pancreatic cancer	2.03e-06	2.63e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	2e-06	2.58e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PTEN—pancreatic cancer	2e-06	2.58e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MYC—pancreatic cancer	1.98e-06	2.56e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—TGFB1—pancreatic cancer	1.98e-06	2.56e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—EGFR—pancreatic cancer	1.94e-06	2.51e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PPARG—pancreatic cancer	1.93e-06	2.49e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	1.93e-06	2.49e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PTEN—pancreatic cancer	1.92e-06	2.48e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—APOE—pancreatic cancer	1.89e-06	2.45e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	1.88e-06	2.43e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PTEN—pancreatic cancer	1.88e-06	2.43e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CD—pancreatic cancer	1.88e-06	2.43e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CB—pancreatic cancer	1.87e-06	2.42e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PTGS2—pancreatic cancer	1.86e-06	2.41e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PTGS2—pancreatic cancer	1.85e-06	2.4e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—KRAS—pancreatic cancer	1.83e-06	2.37e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.79e-06	2.32e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.79e-06	2.32e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—AKT1—pancreatic cancer	1.78e-06	2.3e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CA—pancreatic cancer	1.77e-06	2.3e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PTEN—pancreatic cancer	1.77e-06	2.29e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	1.76e-06	2.27e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—AKT1—pancreatic cancer	1.71e-06	2.22e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	1.71e-06	2.21e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CA—pancreatic cancer	1.68e-06	2.18e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	1.68e-06	2.17e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PTGS2—pancreatic cancer	1.66e-06	2.15e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PPARG—pancreatic cancer	1.65e-06	2.13e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CB—pancreatic cancer	1.64e-06	2.12e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PTEN—pancreatic cancer	1.62e-06	2.1e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PTGS2—pancreatic cancer	1.62e-06	2.1e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PTEN—pancreatic cancer	1.62e-06	2.09e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—HRAS—pancreatic cancer	1.56e-06	2.01e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	1.53e-06	1.98e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTGS2—pancreatic cancer	1.52e-06	1.96e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	1.5e-06	1.94e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—APOE—pancreatic cancer	1.46e-06	1.89e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PTEN—pancreatic cancer	1.45e-06	1.88e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—AKT1—pancreatic cancer	1.45e-06	1.88e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PTEN—pancreatic cancer	1.42e-06	1.83e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CA—pancreatic cancer	1.41e-06	1.82e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—AKT1—pancreatic cancer	1.37e-06	1.78e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	1.35e-06	1.75e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	1.33e-06	1.72e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTEN—pancreatic cancer	1.32e-06	1.71e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.32e-06	1.7e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	1.31e-06	1.69e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTGS2—pancreatic cancer	1.3e-06	1.68e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.27e-06	1.64e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CA—pancreatic cancer	1.25e-06	1.62e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.16e-06	1.5e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—AKT1—pancreatic cancer	1.15e-06	1.49e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	1.15e-06	1.48e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CA—pancreatic cancer	1.14e-06	1.47e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTEN—pancreatic cancer	1.13e-06	1.46e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—AKT1—pancreatic cancer	1.11e-06	1.43e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—AKT1—pancreatic cancer	1.08e-06	1.4e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1.02e-06	1.32e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—AKT1—pancreatic cancer	1.02e-06	1.32e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.01e-06	1.31e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1e-06	1.29e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CA—pancreatic cancer	9.98e-07	1.29e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—AKT1—pancreatic cancer	9.36e-07	1.21e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	9.33e-07	1.21e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—AKT1—pancreatic cancer	9.31e-07	1.2e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTEN—pancreatic cancer	8.72e-07	1.13e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—AKT1—pancreatic cancer	8.36e-07	1.08e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—AKT1—pancreatic cancer	8.16e-07	1.06e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	7.97e-07	1.03e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—AKT1—pancreatic cancer	7.62e-07	9.86e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—AKT1—pancreatic cancer	6.51e-07	8.43e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	6.15e-07	7.96e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—AKT1—pancreatic cancer	5.03e-07	6.5e-06	CbGpPWpGaD
